Rhine Pharma
Phase 3Our mission is to enhance worldwide patient access to targeted theranostics through the generator-produced radioisotopes: Rhenium-188 and Technetium-99m
Founded
2018
Focus
RadiopharmaceuticalsSmall Molecules
About
Our mission is to enhance worldwide patient access to targeted theranostics through the generator-produced radioisotopes: Rhenium-188 and Technetium-99m
Company Info
TypePrivate
Founded2018
LocationCologne, Germany
StagePhase 3
Contact
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile